psychosis Clinical Research Trials

Found 524 clinical trials

featured

A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6-months with Abilify MyCite®

To compare inpatient psychiatric hospitalization rates (proportion of subjects with ≥ 1 inpatient psychiatric hospitalizations) between the retrospective period (Months 1 to 3) while subjects are on oral standard-of-care antipsychotic treatment and the prospective period (Months 1 to 3) after the subjects switch to Abilify MyCite®.

26 views
23 Nov, 2020
1 location

featured

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients with Schizophrenia and Recent Weight Gain While Taking Antipsychotic Medications

To assess the efficacy of miricorilant compared with placebo in reversing recent antipsychoticinduced weight gain (AIWG)

45 views
23 Nov, 2020
1 location

featured

A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia

The primary objective of the study is to evaluate the long-term safety and tolerability of TV-46000 administered in adult and adolescent patients with schizophrenia.

19 views
23 Nov, 2020
1 location

featured

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment period in patients with schizophrenia

This study tests whether BI 425809 together with brain training using a computer improves mental functioning in patients with schizophrenia.

51 views
23 Nov, 2020
1 location

featured

Schizophrenia with Changes in Thinking Skills

Local study doctors are conducting this clinical research study to learn more about an oral investigational drug that is taken with your current schizophrenia medication. They want to evaluate the safety and effectiveness of the investigational drug when it is taken once daily for 12 weeks. All study-related visits, tests, …

77 views
23 Nov, 2020
1 location

featured

Schizophrenia Relapse Prevention

This study tests whether the investigational drug prevents patients with schizophrenia from becoming worse. This study looks at how well patients tolerate the investigational drug and how effective it is over 6 months. All study-related visits and tests, as well as the study drug, will be provided at no cost. …

50 views
23 Nov, 2020
1 location

featured

Add-On Treatment for Schizophrenia Symptom Management

The primary objective of this study is to evaluate the effectiveness of NaBen® (sodium benzoate) (1000 mg/day) compared to Placebo (0 mg/day), in improving symptoms associated with schizophrenia in adults, when added to your current schizophrenia treatment.